Trinity’s ISPOR Annual 2022 Presentation Schedule

Home / Intelligence / Blog / Trinity’s ISPOR Annual 2022 Presentation Schedule

Register now to watch our virtual issue panel or view our in-person and virtual posters – or email: info@trinitylifesciences.com to discuss one of our presentations listed below.

Virtual Issue Panel:

Tuesday, May 17 | 4:30 pm EDT

IP14: The Challenges of Bringing Cell & Gene Therapies to Emerging Markets

A panel of experts from different markets share their experiences and perspectives about the challenges associated with the access and funding of cell and gene therapies, given the issues associated with their upfront costs and potential long term clinical benefits.

Moderator:
Valeria Boers-Trilles, MPhil – Director

Panelists:
Guvenc Kockaya, PhD – ECONiX
Renata Curi Hauegen, PhD – Former Fiocruz / MoH Brazil
Sean Nagle, MPH – Novartis


Research Posters:

Session 2 | Monday, May 16 | 5:30pm EDT

In-Person

SA13: Utilization of Bloodwork and Routine Medical Visits in the US General Population: Analysis of the Optum Claims Data

Virtual

HTA19: The Influence of ICER: Cost-Effectiveness and Decision-Making for USA Payers

Virtual

PCR55: Analyzing the Relationship Between Social Determinants of Health (SDOH) on Hospital Capacity for COVID-19 Patients by Geographic Region

Session 3 | Tuesday, May 17 | 12:15pm EDT

In-Person

EE215: Higher Work Impairment and Increased Healthcare Resource Utilization in Patients with Crohn’s Perianal Fistula: Results from a Global Burden of Illness Study

Session 4 | Tuesday, May 17 | 5:30pm EDT

In-Person

SA34: Impact of COVID-19 on Telehealth Utilization: Analysis of Komodo Healthcare Map™ Claims Data

In-Person

RWD93: Trends in Cell and Gene Therapy Uptake and Utilization in the United States: A Real-World Analysis of the Komodo Healthcare Map™ Claims Data from 2015-2021

In-Person

SA37: Economic and Health-Related Quality of Life Burden in Endogenous Cushing’s Syndrome: A Systematic Literature Review

Virtual

HTA53: Combination Therapies – Two is Company, but is Three (or More) a Concern?

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.